Stanford researchers have developed a mouth-cooling device that prevents or reduces the degree of oral mucositis (OM), a painful side effect of chemotherapy, radiotherapy, autoimmune conditions, and infections.
Researchers at Stanford have developed a technology that uses biomechanical force to initiate T-cell triggering in a high throughput method, facilitating the exploration of the force- and sequence-dependent landscape of T-cell responses.
Prof. Alison Marsden and her colleagues have developed a computational framework that uses personalized anatomical information to identify patients that have a high risk for saphenous vein graft (SVG) failure after coronary artery bypass graft (CABG).
Stanford researchers have developed a new method for producing high-quality lead-germanium-selenide (PbGeSe) thin films with improved optical performance and uniformity.
Researchers at Stanford have developed chemically defined, polyvinyl alcohol (PVA)-based media for culturing hematopoietic stem cells and immune cells (e.g., T cells).
Researchers at Stanford and the Chan Zuckerberg Biohub have developed a platform for characterizing a population of microbes using spectrally encoded beads.
Stanford researchers at the Woo Lab have invented a composite inclusion graft that addresses several challenges associated with the Ross procedure, such as late autograft dilation.
Stanford researchers in the Lin Lab have identified kinase-modulated bioluminescent indicators (KiMBIs) which can assess real time kinase inhibition in target tissues in vivo.
Acute and end stage renal disease affects patients across all ages. Pediatric patients are usually treated with hemodialysis, which requires them to be surgically implanted with a central venous catheter (CVC) for dialysis access.
Stanford inventors in the Katrin Svensson laboratory have identified the protein Isthmin-1 (ISM1) as a treatment for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
The blood-brain barrier (BBB) remains a major obstacle to developing effective therapies for neurological and neurodegenerative disease, because most drugs and biologics do not efficiently reach brain tissue.
Researchers in Prof. A.C. Matin's laboratory have developed a versatile exosome (extracellular vesicle, "EV") drug delivery platform that can selectively target therapeutic agents to tumors or other tissues that overexpress extracellular receptors.
Stanford researchers have demonstrated a new passive cavitation mapping algorithm based on sound localization of multiple scatters of cavitation. It shows improved resolution as compared to existing passive cavitation mapping algorithms based on a basic beamforming.
Stanford researchers have developed an efficient and low-cost device which increases the energy harvest of a system by recovering these losses through module-level maximum power point tracking (MPPT).